338例手术治疗垂体腺瘤的回顾性分析
回顾性分析2016—2020年在本院接受手术切除的338例垂体腺瘤患者(女性169例,平均年龄50.01±12.47岁),依据术后免疫组化进行病理分类,统计临床、影像、实验室及随访资料。结果显示无功能腺瘤患者较功能腺瘤患者年龄更大、肿瘤直径更大,且海绵窦侵犯和垂体卒中的发生率更高(P<0.05);术前垂体前叶功能减退与男性及肿瘤直径相关(P<0.05),非功能腺瘤中预测术前垂体功能减退的肿瘤直径最佳截断值为1.95 cm,术后复发的最佳截断值为2.75 cm。
要点
- 无功能腺瘤(245例)较功能腺瘤(93例)患者年龄更大、肿瘤直径更大,海绵窦侵犯和垂体卒中发生率更高(P<0.05)。
- 术后激素染色以ACTH(27.4%)和FSH/LH阳性(20.6%)最常见,23.1%的无功能腺瘤激素染色阴性。
- 非功能腺瘤中预测术前垂体功能减退的肿瘤直径最佳截断值为1.95 cm,预测术后复发的最佳截断值为2.75 cm。
核心结论
- 手术治疗垂体腺瘤的管理受限于病理分类、垂体功能减退评估及复发检测方面的不足。
研究设计与样本
- 回顾性分析2016—2020年在本院接受手术切除的338例垂体腺瘤患者,女性169例,平均年龄50.01±12.47岁,依据术后免疫组化进行病理分类,使用SPSS v25.0进行统计分析。
主要发现
- 无功能腺瘤组245例较功能腺瘤组93例年龄更大、肿瘤直径更大,海绵窦侵犯率和垂体卒中发生率更高(P<0.05)。
- 术后激素染色最常见为ACTH阳性(27.4%)和FSH/LH阳性(20.6%),23.1%的无功能腺瘤激素染色阴性。
- 术前垂体前叶功能减退常累及性腺轴和甲状腺轴,与男性及肿瘤直径相关(P<0.05)。
- 非功能腺瘤中预测术前垂体功能减退的肿瘤直径最佳截断值为1.95 cm。
- 手术次数和术前垂体功能减退与术后垂体功能障碍相关(P<0.05);非功能腺瘤中肿瘤直径是术后复发的危险因素(最佳截断值2.75 cm)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To summarize the clinical characteristics, pituitary function assessment, postoperative pathological features, and postoperative recurrence of surgically treated pituitary adenomas (PAs). METHODS: We retrospectively reviewed the data of 338 patients (169 women; average age: 50.01 ± 12.47 years) who underwent surgical PA resection at our hospital during 2016-2020. Pathological PA classification was based on postoperative immunohistochemical staining for pituitary hormones. The clinical, imaging, laboratory, and follow-up data of the patients were statistically analyzed using SPSS v25.0. RESULTS: The main complaints of PA patients were compressive symptoms, followed by endocrine symptoms; 23 tumors were incidentalomas. Compared with the 93 patients with functioning PAs, the 245 patients with non-functioning PAs were older, and had greater tumor diameters and rates of cavernous sinus invasion and pituitary apoplexy (P < 0.05). Postoperative hormonal staining most commonly revealed ACTH (27.4%) and FSH/LH positivity (20.6%); 23.1% of non-functioning tumors stained negative for pituitary hormones. Preoperative anterior hypopituitarism commonly involved the gonadal and thyroid axes, and was correlated with male sex and tumor diameter (P < 0.05). The optimal cut-off for tumor diameter was 1.95 cm for predicting preoperative hypopituitarism in patients with non-functioning PAs. The number of operations and preoperative hypopituitarism were correlated with postoperative pituitary dysfunction (P < 0.05). In the non-functioning PA group, tumor diameter was a risk factor for postoperative recurrence (optimal cutoff: 2.75 cm). CONCLUSIONS: The management of patients with surgically treated PAs is limited by deficiencies in pathological classification, assessment of hypopituitarism, and detection of recurrence.
引用
- Xu X, Liu R, Yang X, et al. A retrospective analysis of 338 surgically treated pituitary adenomas. World Neurosurg. 2025. PMID: 39855545. doi:10.1016/j.wneu.2025.123701
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。